Uploaded May 2025 | Updated September 2026, 2 hours ago
Next week, earnings from Novo Nordisk, Palantir and Next will be in focus. Can Novo Nordisk maintain strong sales targets despite rising competition and US healthcare funding challenges? Will Palantir demonstrate strong growth and expand its AI platform to more commercial clients to reassure investors? Can Next continue to beat expectations despite the challenges faced by UK shops?
We break down what to expect and what investors should watch.
Don’t forget to like, subscribe, and stay up to date with all the latest earnings insights.
This is not personal advice or a recommendation to buy, sell, or hold any investment. Investments can fall as well as rise in value, so investors could lose money. If you’re unsure, seek advice. A director of Hargreaves Lansdown plc is a Non-Executive Director of Next plc.
Next week, earnings from Novo Nordisk, Palantir and Next will be in focus. Can Novo Nordisk maintain strong sales targets despite rising competition and US healthcare funding challenges? Will Palantir demonstrate strong growth and expand its AI platform to more commercial clients to reassure investors? Can Next continue to beat expectations despite the challenges faced by UK shops?
We break down what to expect and what investors should watch.
Don’t forget to like, subscribe, and stay up to date with all the latest earnings insights.
This is not personal advice or a recommendation to buy, sell, or hold any investment. Investments can fall as well as rise in value, so investors could lose money. If you’re unsure, seek advice. A director of Hargreaves Lansdown plc is a Non-Executive Director of Next plc.
